Latest UK News
MRC is pleased to announce a new Experimental Medicine Panel, which will meet regularly to enhance the MRC’s current translational offering.
Understanding the reasons for vulnerability to COVID-19 and the differential social, cultural and economic impacts of the pandemic on minority ethnic groups.
Six new projects to improve our understanding of the links between COVID-19 and ethnicity have been funded by UK Research and Innovation’s (UKRI) Medical Research Council (MRC) and the National Institute for Health Research (NIHR).
UK Research and Innovation has awarded £3 million to support six research networks that will investigate solutions to air pollution.
Early stage human trials of a COVID-19 vaccine have found it produces strong immune response and shows no early safety concerns, according to results published today in The Lancet.
Today, UKRI and NIHR are announcing £8.4 million funding for one of the world’s largest studies into the long-term physical and mental health impacts of coronavirus on hospitalised patients.
The UKRI Coronavirus Hub gives you the latest information on the vital work of UKRI and our community in response to the crisis, what grants and awards we have made, and our continuing call to fund your ideas to limit the outbreak and protect life.
Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug commonly used to treat HIV, had no significant mortality benefit in hospitalised COVID-19 patients.
New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes
Testing for coronavirus infection could become quicker, more convenient and more accurate, following the launch of a multicentre national programme of research that will evaluate how new diagnostic tests perform in hospitals, general practices and care homes.
A new study has been funded to analyse samples from 20,000 people with myalgic encephalomyelitis (ME), also diagnosed as chronic fatigue syndrome (CFS, or ME/CFS), to search for genetic differences that may indicate underlying causes or increase the risk of developing the condition.
The first healthy volunteer has now received a new coronavirus vaccine developed by researchers led by Professor Robin Shattock at Imperial College London. The phase I trials were funded by UKRI as part of the UKRI/DHSC/NIHR COVID-19 rapid research response.
Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19
The ‘RECOVERY’ trial has released preliminary results showing low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19.
To meet the needs of this new environment, the NIHR/UKRI rolling call will close to new applications on 30 June 2020. The NIHR has launched a new ‘Recovery and Learning’ call to better understand and manage the health and social care consequences of the global COVID-19 pandemic.
Council members play a critical role in UKRI’s strategy development and governance, working with their Executive Chair to deliver their council's aims and objectives and to support UKRI's overall mission.
Preliminary results from RECOVERY trial on the use of hydroxychloroquine in hospitalised patients with COVID-19
The 'RECOVERY' trial has released preliminary results showing no effect on mortality from the use of hydroxychloroquine in patients admitted to hospital with COVID-19.
The core focus of the webinar will be to provide an introduction to the APDP initiative and our newly appointed Director, Professor David Walsh. Participants will receive an overview of the Advanced Pain Discovery Platform (APDP) initiative, including its scientific scope, eligibility requirements, and the application process.
Scientists have long debated which genetic information carrier – DNA or RNA – started life on Earth, but a new study suggests life could have begun with a bit of both.
The Medical Research Council and Versus Arthritis and other Partners are pleased to announce the appointment of Professor David Walsh as Director for the UKRI Strategic Priorities Fund (SPF) Programme, Advanced Pain Discovery Platform (APDP).
The MRC in partnership with The Observer are proud to announce that the Max Perutz Science Writing Award 2020 is now open.
MRC-supported scientists are among the distinguished medical researchers elected as Fellows of the Academy of Medical Sciences.